Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus

被引:2
|
作者
Song, Do Kyeong [1 ]
Hong, Young Sun [1 ]
Sung, Yeon-Ah [1 ]
Lee, Hyejin [1 ]
机构
[1] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea
来源
PLOS ONE | 2024年 / 19卷 / 02期
关键词
CAUSE-SPECIFIC MORTALITY; MULTIFACTORIAL INTERVENTION; BLOOD-PRESSURE; DISEASE; OUTCOMES;
D O I
10.1371/journal.pone.0299035
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Since patients with type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular events, interventions addressing risk factors reduce the incidence of cardiovascular disease (CVD) events. This study aimed to evaluate the difference in the incidence of CVD events according to risk factor control in patients with diabetes with and without cardio-renal disease.Methods We analyzed 113,909 patients with diabetes and 290,339 without diabetes using data released by the National Health Insurance Service (NHIS).Results Among patients with diabetes with four or five poorly controlled risk factors, hazard ratio for CVD events was 1.19 (95% confidence interval [CI], 1.06-1.34) in patients with cardio-renal disease and 2.31 (95% CI, 1.95-2.74) in patients without cardio-renal disease compared to patients with diabetes without risk factors. In subjects with diabetes and cardio-renal disease, patients with four or five poorly controlled risk factors had a higher risk of CVD mortality compared to subjects without risk factors (hazard ratio, 1.64; 95% CI, 1.18-2.30).Conclusion Controlling cardiovascular risk factors reduced the incidence of CVD events in patients with diabetes, especially those without cardio-renal disease. The degree of risk control was strongly associated with CVD mortality in patients with diabetes with baseline cardio-renal disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Risk for cardiovascular events in an Italian population of patients with type 2 diabetes
    Pellegrini, E.
    Maurantonio, M.
    Giannico, I. M.
    Simonini, M. S.
    Ganazzi, D.
    Carulli, L.
    D'Amico, R.
    Baldini, A.
    Loria, P.
    Bertolotti, M.
    Carulli, N.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (11) : 885 - 892
  • [32] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [33] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [34] Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
    Lincoff, A. Michael
    Wolski, Kathy
    Nicholls, Stephen J.
    Nissen, Steven E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10): : 1180 - 1188
  • [35] Type 2 diabetes mellitus in primary care: Control of cardiovascular risk factors
    Mantilla, T.
    Garcia Serrano, B.
    Gomez de Celis, M. I.
    Alvarez, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 102 - 102
  • [36] Control of cardiovascular risk factors in type 2 Diabetes Mellitus in primary care
    Mantilla, T
    de Oteyza, CP
    de la Cámara, AG
    de Caso, A
    Alvarez-Sala, L
    JOURNAL OF HYPERTENSION, 2005, 23 : S210 - S210
  • [37] Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus
    Marshall, SM
    DIABETIC MEDICINE, 1999, 16 (05) : 358 - 372
  • [38] Control of cardiovascular risk factors in type 2 diabetes mellitus in primary care
    Mantilla, T.
    De Oteyza, C. Perez
    De la Camara, A. Gomez
    Alvarez-Sala, L.
    De Caso, M. D. Alonso
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 58 - 59
  • [39] Blood pressure control and impact on cardiovascular events in patients with type 2 diabetes mellitus: A critical analysis of the literature
    Vargas-Uricoechea, Hernando
    Felipe Caceres-Acosta, Manuel
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2019, 31 (01): : 31 - 47
  • [40] Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus
    Fenske, Wiebke
    Wanner, Christoph
    Allolio, Bruno
    Drechsler, Christiane
    Blouin, Katja
    Lilienthal, Juergen
    Krane, Vera
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (04): : 782 - 790